[1]
|
Cherfils, J. and Zeghouf, M. (2013) Regulation of Small GTPases by GEFs, GAPs and GDIs. Physiologjcal Reviews, 93, 269-309. https://doi.org/10.1152/physrev.00003.2012
|
[2]
|
Bos, J.L., Rehmann, H. and Wittinghofer, A. (2007) GEFs and GAPs: Critical Elements in the Control of Small G Proteins. Cell, 129, 865-877. https://doi.org/10.1016/j.cell.2007.05.018
|
[3]
|
Buday, L. and Downward, J. (2008) Many Faces of Ras Activation. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1786, 178-187. https://doi.org/10.1016/j.bbcan.2008.05.001
|
[4]
|
Zhang, Z., Gao, R., Hu, Q., Peacock, H., Peacock, D.M., Dai, S., Shokat, K.M. and Suga, H. (2020) GTP-State-Selective Cyclic Peptide Ligands of K-Ras (G12D) Block Its Interaction with Raf. ACS Central Science, 6, 1753-1761. https://doi.org/10.1021/acscentsci.0c00514
|
[5]
|
Hillig, R.C. and Bader, N. (2022) Chapter Six: Targeting RAS on Cogenesis with SOS1 Inhibitors. In: O’Bryan, J.P. and Piazza, G.A., Eds., Advances in Cancer Research, Vol. 153, Academic Press, Cambridge, 169-203.
https://doi.org/10.1016/bs.acr.2021.07.001
|
[6]
|
Hoang, H.M., Umutesi, H.G. and Heo, J. (2021) Allosteric Autoactivation of SOS and Its Kinetic Mechanism. Small GTPases, 12, 44-59. https://doi.org/10.1080/21541248.2019.1601954
|
[7]
|
Bandaru, P., Kondo, Y. and Kuriyan, J. (2019) The Interdependent Activation of Son-of-Sevenless and Ras. Cold Spring Harbor Perspectives in Medicine, 9, 1-14. https://doi.org/10.1101/cshperspect.a031534
|
[8]
|
Lee, Y.K., Low-Nam, S.T., Chung, J.K., Hansen, S.D., Lam, H.Y.M., Alvarez, S. and Groves, J.T. (2017) Mechanism of SOS PR-Domain Autoinhibition Revealed by Single-Molecule Assays on Native Protein from Lysate. Nature Communications, 8, Article No. 15061. https://doi.org/10.1038/ncomms15061
|
[9]
|
Toma-Fukai, S. and Shimizu, T. (2019) Structural Insights into the Regulation Mechanism of Small GTPases by GEFs. Molecules, 24, Article 3308. https://doi.org/10.3390/molecules24183308
|
[10]
|
Gureasko, J., Kuchment, O., Makino, D.L., Sondermann, H., Bar-Sagi, D. and Kuriyan, J. (2010) Role of the Histone Domain in the Autoinhibition and Activation of the Ras Activator Son of Sevenless. PNAS, 107, 3430-3405.
https://doi.org/10.1073/pnas.0913915107
|
[11]
|
Zarich, N., Anta, B., Fernandez-Medarde, A., Ballester, A., de Lucas, M.P., Camara, A.B., Anta, B., Oliva, J.L., Rojas-Cabaneros, J.M. and Santos, E. (2019) The CSN3 Subunit of the COP9 Signalo Some Interacts with the HD Region of SOS1 Regulating Stability of this GEF Protein. Oncogenesis, 8, Article No. 2.
https://doi.org/10.1038/s41389-018-0111-1
|
[12]
|
Soisson, S.M., Nimnual A.S., Uy, M., Bar-Sagi, D. and Kuriyan, J. (1998) Crystal Structure of the Dbl and Pleckstrin Homology Domains from the Human Son of Sevenless Protein. Cell, 95, 259-268.
https://doi.org/10.1016/S0092-8674(00)81756-0
|
[13]
|
Gureasko, J., Galush, Boykevisch, W.J., Sondermann, S.H., Bar-Sagi, D., Groves, J.T. andKuriyan, J. (2008) Membrane-Dependent Signal Integration by the Ras Activator Son of Sevenless. Nature Structural & Molecular Biology, 15, 452-461. https://doi.org/10.1038/nsmb.1418
|
[14]
|
Yadav, K.K. and Bar-Sagi, D. (2010) Allosteric Gating of Son of Sevenless Activity by the Histone Domain. PNAS, 107, 3436-3440. https://doi.org/10.1073/pnas.0914315107
|
[15]
|
Margarit, S.M., Sondermann, H., Hall, B.E., Nagar, B., Hoelz, A., Pirruccello, M., Bar-Sagi, D. and Kuriyan, J. (2003) Structural Evidence for Feedback Activation by Ras∙GTP of the Ras-Specific Nucleotide Exchange Factor SOS. Cell, 112, 685-695. https://doi.org/10.1016/S0092-8674(03)00149-1
|
[16]
|
Boriack-Sjodin, P.A., Margarit, S.M., Bar-Sagi, D. and Kuriyan, J. (1998) The Structural Basis of the Activation of Ras by SOS. Nature, 394, 337-343. https://doi.org/10.1038/28548
|
[17]
|
Hall, B.E., Yang, S.S., Boriack-Sjodin, P.A., Kuriyan, J. and Bar-Sagi, D. (2001) Structure-Based Mutagenesis Reveals Distinct Functions for Ras Switch 1 and Switch 2 in SOS-Catalyzed Guanine Nucleotide Exchange. Journal of Biological Chemistry, 276, 27629-27637. https://doi.org/10.1074/jbc.M101727200
|
[18]
|
Vo, U., Vajpai, N., Flavell, L., Bobby, R., Breeze, A.L., Embrey, K.J. and Golovanov, A.P. (2016) Monitoring Ras Interactions with the Nucleotide Exchange Factor Son of Sevenless (SOS) Using Site-Specific NMR Reporter Signals and Intrinsic Fluorescence. Journal of Biological Chemistry, 291, 1703-1718. https://doi.org/10.1074/jbc.M115.691238
|
[19]
|
Freedman, T.S., Sondermann, H., Kuchment, O., Friedland, G.D., Kortemme, T. and Kuriyan, J. (2009) Differences in Flexibility Underlie Functional Differences in the Ras Activators Son of Sevenless and Ras Guanine Nucleotide Releasing Factor 1. Structure, 17, 41-53. https://doi.org/10.1016/j.str.2008.11.004
|
[20]
|
Sondermann, H., Soisson, S.M., Boykevisch, S., Yang, S.S., Bar-Sagi, D. and Kuriyan, J. (2004) Structural Analysis of Autoinhibition in the Ras Activator Son of Sevenless. Cell, 119, 393-405. https://doi.org/10.1016/j.cell.2004.10.005
|
[21]
|
Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. and Saltiel, A.R. (1995) PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-Activated Protein Kinase Kinase in Vitro and in Vivo. Journal of Biological Chemistry, 270, 27489-27494. https://doi.org/10.1074/jbc.270.46.27489
|
[22]
|
Zarich, N., Oliva, J.L., Martinez, N., Jorge, R., Ballester, A., Gutierrez-Eisman, S., Garcia-Vargas, S. and Rojas, J.M. (2006) Grb2 Is a Negative Modulator of the Intrinsic Ras-GEF Activity of HSOS1. Molecular Biology of the Cell, 17, 3591-3597. https://doi.org/10.1091/mbc.e05-12-1104
|
[23]
|
Corbalán-García, S., Margarit, S.M., Galron,D., Yang, S.S. and Bar-Sagi, D. (1998) Regulation of SOS Activity by Intramolecular Interactions. Molecular and Cellular Biology, 18, 880-886. https://doi.org/10.1128/MCB.18.2.880
|
[24]
|
Nimnual, A. and Bar-Sagi, D. (2002) The Two Hats of SOS. Science Signaling, 2002, epe36.
https://doi.org/10.1126/stke.2002.145.pe36
|
[25]
|
Rojas, J.M., Oliva, J.L. and Santos, E. (2011) Mammalian Son of Sevenless Guanine Nucleotide Exchange Factors: Old Concepts and New Perspectives. Genes & Cancer, 2, 298-305. https://doi.org/10.1177/1947601911408078
|
[26]
|
Pierre, S., Bats, A.S. and Coumoul, X. (2011) Understanding SOS (Son of Sevenless). Biochemical Pharmacology, 82, 1049-1056. https://doi.org/10.1016/j.bcp.2011.07.072
|
[27]
|
Christensen, S.M., Tu, H.-L., Jun, J.E., Alvarez, S., Triplet, M.G., Iwig, J.S., Yadav, K.K., Bar-Sagi, D., Roose, J.P. and Groves, J.T. (2016) One-Way Membrane Trafficking of SOS in Receptor-Triggered Ras Activation. Nature Structural & Molecular Biology, 23, 838-846. https://doi.org/10.1038/nsmb.3275
|
[28]
|
Ambrogio, C. (2021) ES28.03 Mechanisms of Resistance to KRAS G12C Inhibitors. Journal of Thoracic Oncology, 16, S96. https://doi.org/10.1016/j.jtho.2021.01.062
|
[29]
|
Corbalan-Garcia, S., Yang, S.S., Degenhardt K.R. and Bar-Sagi D. (1996) Identification of the Mitogen-Activated Protein Kinase Phosphorylation Sites on Human SOS1 that Regulate Interaction with Grb2. Molecular and Cellular Biology, 16, 5674-5682. https://doi.org/10.1128/MCB.16.10.5674
|
[30]
|
Rozakis-Adcock, M., van der Geer, P., Mbamalu, G. and Pawson, T. (1995) MAP Kinase Phosphorylation of mSos1 Promotes Dissociation of mSos1-Shc and mSos1-EGF Receptor Complexes. Oncogene, 11, 1417-1426.
|
[31]
|
Thompson, S.K., Buckl, A., Dossetter, A.G., Griffen, E. and Gill, A. (2021) Small Molecule Son of Sevenless 1 (SOS1) Inhibitors: A Review of the Patent Literature. Expert Opinion on Therapeutic Patents, 31, 1189-1204.
https://doi.org/10.1080/13543776.2021.1952984
|
[32]
|
Hillig, R.C., Sautier, B., Schroeder, J., Moosmayer, D., Hilpmann, A., Stegmann, C.M., Werbeck, N.D., Briem, H., Boemer, U., Weiske, J., Badock, V., Mastouri, J., Petersen, K., Siemeister, G., Kahmann, J.D., Wegener, D., Bohnke, N., Eis, K., Graham, K., Wortmann, L., von Nussbaum, F. and Bader, B. (2019) Discovery of Potent SOS1 Inhibitors that Block RAS Activation via Disruption of the RAS-SOS1 Interaction. Proceedings of the National Academy of Sciences of the United States of America, 116, 2551-2560. https://doi.org/10.1073/pnas.1812963116
|
[33]
|
Liceras-Boillos, P., Jimeno, D., Garcia-Navas, R., Lorenzo-Martin, L.F., Menacho-Marquez, M., Segrelles, C., Gomez, C., Calzada, N., Fuentes-Mateos, R., Paramio, J.M., Bustelo, X.R., Baltanas, F.C. and Santos, E. (2018) Differential Role of the RasGEFs SOS1 and SOS2 in Mouse Skin Homeostasis and Carcinogenesis. Molecular and Cellular Biology, 38, 4538-4551. https://doi.org/10.1128/MCB.00049-18
|
[34]
|
Hofmann, M.H., Gmachl, M., Ramharter, J., Savarese, F., Gerlach, D., Marszalek, J.R., Sanderson, M.P., Kessler, D., Trapani, F., Arnhof, H., Rumpel, K., Botesteanu, D.A., Ettmayer, P., Gerstberger, T., Kofink, C., Wunberg, T., Zoephel, A., Fu, S.C., Teh, J.L., Bottcher, J., Pototschnig, N., Schachinger, F., Schipany, K., Lieb, S., Vellano, C.P., O’Connell, J.C., Mendes, R.L., Moll, J., Petronczki, M., Heffernan, T.P., Pearson, M., McConnell, D.B. and Kraut, N. (2021) BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition. Cancer Discovery, 11, 142-157. https://doi.org/10.1158/2159-8290.CD-20-0142
|
[35]
|
唐春雷, 范懿庆, 范为正, 姜虹羽, 等. 一种取代喹唑啉类化合物、药物组合物及其用途[P]. 中国专利, 115141188. 2022-10-04.
|
[36]
|
He, H., Zhang, Y., Xu, J., Li, Y., Fang, H., Liu, Y. and Zhang, S. (2022) Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma. Journal of Medicinal Chemistry, 65, 13158-13171.
https://doi.org/10.1021/acs.jmedchem.2c00986
|
[37]
|
Hofmann, M.H., Lu, H., Duenzinger, U., Gerlach, D., Trapani, F., Machado, A.A., Daniele, J.R., Waizenegger, I., Gmachl, M., Rudolph, D., Vellano, C.P., Marotti, M., Vucenovic, V., Heffernan, T.P., Marszalek, J.R., Petronczki, M.P. and Kraut, N. (2021) Abstract CT210: Trial in Process: Phase 1 Studies of BI 1701963, a SOS1: KRAS Inhibitor, in Combination with MEK Inhibitors, Irreversible KRASG12C Inhibitors or Irinotecan. Cancer Reaserch, 81, CT210.
https://doi.org/10.1158/1538-7445.AM2021-CT210
|
[38]
|
Theard, P.L., Sheffels, E., Sealover, N.E., Linke, A.J., Pratico, D.J. and Kortum, R.L. (2020) Marked Synergy by Vertical inhibition of EGFR Signaling in NSCLC Spheroids Shows SOS1 Is a Therapeutic Target in EGFR-Mutated Cancer. eLife, 9, e58204. https://doi.org/10.7554/eLife.58204
|